Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

"Declarations Ethics approval and consent to participateThe study was approved by the Universitair Ziekenhuis Brussel Ethics Committee (UZ Brussel – BUN 143201941207). All participants gave written informed consent. Consent for publicationN/A. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by Fonds Wetenschappelijk Onderzoek (FWO), Flanders, grant number B040419N. We gratefully acknowledge the Brussels-Capital Region—Innoviris (Brussels Public Organisation for Research and Innovation) for financial support of the DetectDem research platform (2022-RPF-1). The funders had no role in study design, data collection, data analysis or interpretation of the data, nor in the writing of the report or decision to submit the article for publication. O.F. is supported by a research grant from the Fonds pour la Formation à la Recherche dans l’Industrie et l’Agriculture (FRIA, Fonds de la Recherche Scientifique (FRS-FNRS), Brussels, Belgium). X.D.T. is Clinical Researcher at the FRS-FNRS. The MEG project at the CUB Hôpital Erasme and the Hôpital Universitaire de Bruxelles is financially supported by the Fonds Erasme (Brussels, Belgium; Research convention: “Les Voies du Savoir”). The PET-MR project at the CUB Hôpital Erasme is financially suppported by the Association Vinçotte Nuclear. G.N. is a senior clinical research fellow of the Fonds Wetenschappelijk Onderzoek (FWO) Flanders: (1805620N, www.fwo.be)."

"Trial registration Clinicaltrials.gov, NCT04131491. 12/02/2020."